Disulfiram Recruiting Phase 2 Trials for Glioblastomas / Glioblastoma Multiforme (GBM) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03363659Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme